Explore more publications!

Health Reporter French Polynesia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Reporter French Polynesia.

Press releases published on November 18, 2025

Olema Oncology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations on Wednesday, November 19, 2025
Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease
SI-BONE To Present at Piper Sandler 37th Annual Healthcare Conference on December 2, 2025
BBOT to Participate in Upcoming December Investor Healthcare Conferences
Neurona Therapeutics Appoints Dr. Eduardo Dunayevich as Chief Medical Officer
Solana Company Reports Third Quarter 2025 Financial Results
Eledon Reports Preliminary Data from First Six Patients with Type 1 Diabetes Treated with Tegoprubart as the Core Immunosuppressant Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine
argenx Announces Results of Extraordinary General Meeting of Shareholders
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Suja Life Announces Confidential Submission of Draft Registration Statement
Rad Source Launches RS® 420 Q+ Boost & RS® 420 MAX – High-Capacity Cannabis Decontamination Solutions
UPDATE – PrognomiQ Launches ProVue Lung, a Proteomics-Based Laboratory Developed Test to Aid in the Early Detection of Lung Cancer
Capsa Healthcare to Showcase Integrated Central Fill Automation at ASHP Midyear 2025
Comprehensive Healthcare Takes Next Step Toward Expanding Access to Behavioral Healthcare in Central Washington
SPRI and Neuromuscular Dynamics Launch NIH-Funded Clinical Trial to Advance Non-Surgical Knee Osteoarthritis Treatment
Genmab Announces EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide Approved by the U.S. Food and Drug Administration for the Treatment of Relapsed or Refractory Follicular Lymphoma
NeuroSigma Launches Next-Generation Monarch Device for Pediatric ADHD After Successful Pilot Program
ALX Oncology to Present at Upcoming Investor Conferences
Sarah Scott Named to Business Insurance’s “Women to Watch” List for 2025

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions